The new members for the term from 2017 to 2019 are General Manager Nina Ekholm of AstraZeneca Oy, Country Division Head Olaf Gerber of Bayer Oy, Country Director Marika Murto of Amgen AB and General Manager Marjukka Suomela of Ferring Lääkkeet Oy. The member elected for the term from 17 November 2016 to the end of the year 2017 is General Manager Matthew Iles of Takeda Oy.
The other members of the Board are General Manager Titus Gylvin of Roche Oy, Board Chairperson Marco Hautalahti of Biogen Finland Oy, General Manager Päivi Kerkola of Pfizer Oy, General Manager Ilpo Tolonen of MSD Finland Oy, General Manager Antti Viitanen of Novartis Finland Oy and Country Director Jenni Vuola of Sanofi Pasteur MSD.
Jyrki Liljeroos of Santen Oy will continue as the PIF Board Chairperson until the end of the current year. In its organising meeting in January 2017, the Board will appoint one of its members as the new Board Chairman.